4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001415889-25-001045
Options or other derivatives
- Chief Scientific Officer acquired 185,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Burrows Francis Chief Scientific Officer | 2025-01-02 | Grant or award · Option to purchase common stock | +185,000 | 185,000 | D | ||
Loading xslF345X05/form4-01072025_100138.xml…